Haven Private’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Haven Private's BMY Position: Q2 2026 in Review
Haven Private reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $43.7K and leaving 5,087 shares worth $293K. The position accounts for 0.11% of the portfolio, ranked #141.
Haven Private first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. The position peaked at $355K in Q1 2026. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Haven Private held 5,087 shares of Bristol-Myers Squibb worth $293K as of Q2 2026.
- Haven Private sold 761 Bristol-Myers Squibb shares in Q2 2026, an estimated $43.7K.
- Bristol-Myers Squibb made up 0.11% of Haven Private's portfolio in Q2 2026, its #141 holding.
- Haven Private first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
- Haven Private's Bristol-Myers Squibb position peaked at $355K in Q1 2026.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Haven Private's 13F filing for Q2 2026, filed 29 Jul 2026.